Global Flow Cytometer Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Flow Cytometer Market was valued at $5.4 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 7.8% CAGR, to an estimated market size of $7.9 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The flow cytometry market comprises laser-based analytical technologies and instruments used for cell analysis, including the characterization, counting, and sorting of individual cells or particles in a fluid stream. The scope includes hardware, reagents, software, and specialized services used in clinical diagnostics, drug discovery, and academic research, while excluding general laboratory equipment not specific to single-cell analysis.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Flow Cytometer Market in the period 2025-30:
- The integration of Artificial Intelligence and machine learning is automating complex data gating and analysis, significantly reducing manual errors and improving reproducibility.
- There is a growing shift toward Multi-omics approaches, where flow cytometry is combined with single-cell genomics and proteomics to provide a more holistic view of cellular functions.
- The rising global prevalence of chronic diseases, particularly cancer and HIV/AIDS, is driving the demand for high-throughput diagnostic and monitoring tools.
- Increasing outsourcing of analytical workflows to specialized Contract Research Organizations (CROs) is helping pharmaceutical companies manage high capital expenditures for advanced equipment.
- Technological advancements in Spectral Flow Cytometry and imaging cytometers are enabling higher multiplexing capabilities and more detailed spatial analysis of cells.
- The expansion of Precision Medicine and stem cell therapies is creating new requirements for highly sensitive and specific cell characterization techniques.
- New regulatory mandates requiring biomarker evaluation for drug approvals are compelling pharmaceutical companies to adopt advanced flow cytometry in early-stage development.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Instruments
- Reagents & Consumables
- Services
- Software
- Accessories